Key result
Early Class IC drugs linked to ~89% sinus rhythm maintenance in paroxysmal AF.
Why the study?
To investigate the efficacy of Vaughan Williams Class IC drugs in preventing the progression of multiple premature atrial contractions toward paroxysmal atrial fibrillation and atrial fibrillation at an earlier stage of histological remodeling.
Do Vaughan Williams Class IC drugs improve the maintenance of sinus rhythm in patients with multiple premature atrial contractions and paroxysmal atrial fibrillation?
Observational (n=21)
No
Do Vaughan Williams Class IC drugs improve the maintenance of sinus rhythm in patients with multiple premature atrial contractions and paroxysmal atrial fibrillation?
Early treatment with Class IC antiarrhythmic drugs may help maintain sinus rhythm and prevent progression in patients with multiple premature atrial contractions and paroxysmal atrial fibrillation.
Answers are grounded in this paper and cite their sources.
May support early Class IC use for sinus rhythm maintenance in mPAC/PAF; hypothesis-generating and requires randomized confirmation.
Background: Atrial fibrillation (A-Fib) poses a significant clinical challenge, particularly in the elderly and those with hypertension. If A-Fib represents one stage in the spectrum of electrical degeneration caused by aging-induced remodeling of the left atrial wall, catheter ablation is not an essential treatment. The efficacy of Vaughan Williams Class IC drug in preventing the progression of multiple premature atrial contractions (mPAC) toward paroxysmal atrial fibrillation (PAF) and A-Fib in the earlier stage of histological change was investigated. Method and results: Group A (4 patients with mPAC) and Group B (9 patients with PAF) were treated with Class IC drugs. Treatment outcomes were compared between these two Groups and Group C (8 patients with chronic A-Fib). Follow-up assessments were performed to evaluate the maintenance of sinus rhythm. All mPAC patients maintained sinus rhythm during the follow-up period. In the PAF group, 8 out of 9 patients maintained their sinus rhythm. Conclusion: Early treatment with Class IC drugs shows promise in preventing the progression of A-Fib and maintaining sinus rhythm in patients with mPAC and PAF. These findings highlight the potential role of pharmacological therapy in delaying the onset of A-Fib, thereby improving clinical outcomes and reducing the need for invasive procedures such as ablation.
No takes yet. Share an insight, caveat, or question.
A. Yamaguchi (2024) conducted an observational in Multiple premature atrial contractions (mPAC) and paroxysmal atrial fibrillation (PAF) (n=21). Vaughan Williams Class IC Drugs (pilsicainide and flecainide) vs. Chronic atrial fibrillation (observational comparison) was evaluated on Maintenance of sinus rhythm. Early treatment with Class IC drugs maintained sinus rhythm in 100% of patients with multiple premature atrial contractions (4/4) and 88.9% of patients with paroxysmal atrial fibrillation (8/9).
Synapse has enriched 10 related papers. Consider them for comparative context: